
    
      TO determine whether there are fewer infections, days without a fever, days on antibiotics
      given for an infection and time to marrow engraftment are improved by intensive glucose
      management; and to determine whether there is evidence of a reduction in measures of
      inflammation in patients randomized to intensive glucose management and whether reduction of
      inflammation is associated with outcome.
    
  